Release Date: 23/04/14 16:17 Summary: Quarterly Report March 2014 Price Sensitive: Yes Download Document 1.65MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%